Clarity Pharmaceuticals Ltd.ASX: CU6

Becoming a substantial holder

· Issued by Clarity Pharmaceuticals Ltd. via ASX

Filed with ASX · · 5 pages · English

Release

Form 603 Notice of initial substantial shareholder Corporations Act Section 671B To: Clarity Pharmaceuticals Ltd (“CU6”, Ordinary Fully Paid) 1. Details of substantial shareholder Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) and each of the related bodies corporate in the...

Clarity Pharmaceuticals Ltd. on 6ix

Earlier from Clarity Pharmaceuticals

All Clarity Pharmaceuticals news releases